Literature DB >> 1687285

Pharmacokinetics of haloperidol decanoate in rats.

Y Oh-e1, H Miyazaki, Y Matsunaga, M Hashimoto.   

Abstract

Plasma levels of haloperidol decanoate and haloperidol after intramuscular administration of haloperidol decanoate in rats showed good fits with a multi-compartment model which was constituted by combination of 2-compartment models for the disposition of haloperidol and for its ester decanoate through the process of hydrolysis of the ester. Calculated parameters indicated that most of intramuscularly administered haloperidol decanoate is absorbed in blood after hydrolysis to haloperidol and the absorption is rate-limiting. Regional lymph node levels suggested that the intramuscularly administered ester was absorbed via the lymphatic system where the hydrolysis to haloperidol probably occurred. Thus, slow entrance and hydrolysis of haloperidol decanoate in the lymphatic system was considered to be the cause of sustained plasma levels of the active principle after intramuscular administration of haloperidol decanoate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1687285     DOI: 10.1248/bpb1978.14.615

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  2 in total

Review 1.  Critical factors influencing the in vivo performance of long-acting lipophilic solutions--impact on in vitro release method design.

Authors:  Susan Weng Larsen; Claus Larsen
Journal:  AAPS J       Date:  2009-11-06       Impact factor: 4.009

2.  The roles of depot injection sites and proximal lymph nodes in the presystemic absorption of fluphenazine decanoate and fluphenazine: ex vivo experiments in rats.

Authors:  J P Luo; J W Hubbard; K K Midha
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.